Top

Published in:

01-08-2009 | Case Report

Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?

Authors: E. Binello, I. M. Germano

Published in: Journal of Neuro-Oncology | Issue 1/2009

Abstract

Glioblastoma multiforme is a primary malignant brain tumor with a prognosis of typically less than 2 years. Standard treatment paradigms include surgery, radiation therapy and temozolomide. Little data exists for temozolomide recommendations after the first 6 months. We present a case of a patient with glioblastoma multiforme treated with surgery, radiation and chronic temozolomide for 6 years. He continues to survive glioblastoma-recurrence-free, but developed tonsillary carcinoma. This case raises the question of whether this secondary solid-organ malignancy is treatment-related or dual pathology.

CBTRUS (2008) Statistical report: primary brain tumors in the United States, 2000–2004. Published by the Central Brain Tumor Registry of the United States. http://www.cbtrus.org. Accessed 8 July 2008

Stupp R, Mason WP, Van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi:10.1056/NEJMoa043330 PubMedCrossRef

Mason WP, Del Maestro R, Eisenstat D et al (2007) Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 14:110–117. doi:10.3747/co.2007.119 PubMedCrossRef

Cohen MH, Johnson JR, Pazdur R (2005) Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 11:6767–6771. doi:10.1158/1078-0432.CCR-05-0722 PubMedCrossRef

Noronha V, Berliner N, Ballen KK, Lacy J, Kracher J, Baehring J, Henson JW (2006) Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neurooncology 8:280–283. doi:10.1215/15228517-2006-003

Su YW, Chang MC, Chiang MF, Hsieh RK (2005) Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neurooncol 71:315–318. doi:10.1007/s11060-004-2028-0 PubMedCrossRef

Jalali R, Singh P, Menon H, Gugral S (2007) Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with temozolomide. J Neurooncol 85:105–107. doi:10.1007/s11060-007-9398-z PubMedCrossRef

Villano JL, Collins CA, Manasanch EE, Ramaprasad C, Besien KV (2006) Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 7:436–438. doi:10.1016/S1470-2045(06)70696-9 PubMedCrossRef

US Cancer Statistics Working Group (2007) United States cancer statistics: 1999–2004 incidence and mortality web-based report. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. http://www.cdc.gov/uscs. Accessed 8 July 2008

10.

Golas SM (2007) Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol 35:98–108. doi:10.1111/j.1600-0528.2007.00299.x PubMedCrossRef

11.

Genden EM, Ferlito A, Scully C, Shaha AR, Higgins K, Rinaldo A (2003) Current management of tonsillar cancer. Oral Oncol 39:337–342. doi:10.1016/S1368-8375(02)00085-4 PubMedCrossRef

12.

Swoboda A, Fabrizii V (1993) Tonsillar carcinoma in a renal transplant patient treated with cyclosporine A. Clin Nephrol 39:272–274PubMed

13.

Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11:448–457. doi:10.1038/sj.cdd.4401359 PubMedCrossRef

14.

Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM (2003) Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J Neurosurg 9:1047–1052

15.

Geiger H, Schleimer D, Nattamai KJ, Dannenmann SR, Davies SM, Weiss BD (2006) Mutagenic potential of temozolomide in bone marrow cells in vivo. Blood 107:3010–3011. doi:10.1182/blood-2005-09-3649 PubMedCrossRef

16.

Freedman RA, Wirth LJ, Chirieac LR, Huang EC (2007) Glioblastoma in a patient with early-stage tonsil cancer. J Clin Oncol 25:2848–2850. doi:10.1200/JCO.2007.11.3530 PubMedCrossRef

Title: Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?
Authors: E. Binello
I. M. Germano
Publication date: 01-08-2009
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2009
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-009-9806-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the prolactinomas and gonadotrope tumors

RETRACTED ARTICLE: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging

Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing

Glioblastoma in multiple sclerosis: a case report

Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases

Multifarious proteomic signatures and regional heterogeneity in glioblastomas